Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This article describes a workflow of techniques employed for testing novel candidate mediators of melanoma metastasis and their mechanism(s) of action.

Abstract

Metastasis is a complex process, requiring cells to overcome barriers that are only incompletely modeled by in vitro assays. A systematic workflow was established using robust, reproducible in vivo models and standardized methods to identify novel players in melanoma metastasis. This approach allows for data inference at specific experimental stages to precisely characterize a gene's role in metastasis. Models are established by introducing genetically modified melanoma cells via intracardiac, intradermal, or subcutaneous injections into mice, followed by monitoring with serial in vivo imaging. Once preestablished endpoints are reached, primary tumors and/or metastases-bearing organs are harvested and processed for various analyses. Tumor cells can be sorted and subjected to any of several 'omics' platforms, including single-cell RNA sequencing. Organs undergo imaging and immunohistopathological analyses to quantify the overall burden of metastases and map their specific anatomic location. This optimized pipeline, including standardized protocols for engraftment, monitoring, tissue harvesting, processing, and analysis, can be adopted for patient-derived, short-term cultures and established human and murine cell lines of various solid cancer types.

Introduction

The high mortality associated with metastatic melanoma combined with an increasing incidence of melanoma worldwide1 (an estimated 7.86% increase by 2025) calls for new treatment approaches. Advances in target discovery hinge upon reproducible models of metastasis, a highly complex process. Throughout the steps of the metastatic cascade, melanoma cells must overcome countless barriers to achieve immune system evasion and colonization of distant tissues2. The resilience and adaptability of melanoma cells arise from a multitude of factors, including their high genetic mutational burden3 and their neu....

Protocol

NOTE: The animal procedures involved in the following protocol were approved by the New York University Institutional Animal Care and Use Committee (IACUC). All the procedures are conducted in facilities approved by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). Figure 1 depicts the general experimental approach.

1. Patient-derived melanoma short-term cultures (STCs)

  1. Place the tissue .......

Representative Results

The following figures illustrate how the described workflow has been applied for the identification of novel drivers of melanoma metastasis. Figure 2 summarizes the results of a published study in which the effects of silencing the fucosyltransferase FUT8 in in vivo melanoma metastasis were studied26. Briefly, analysis of human patient glycomic data (obtained by lectin arrays) and transcriptomic profiling revealed increased levels of alpha-1,6-fucose associat.......

Discussion

The aim of this technical report is to offer a standardized, top-to-bottom workflow for the investigation of potential actors in melanoma metastasis. As in vivo experiments can be costly and time-consuming, strategies to maximize efficiency and increase the value of the information obtained are paramount.

It is imperative to use complementary approaches throughout to crossvalidate findings within the same experiment. For example, both NuMA immunohistochemical staining and BLI are comp.......

Acknowledgements

We thank the Division of Advanced Research Technologies (DART) at NYU Langone Health, and in particular, the Experimental Pathology Research Laboratory, Genome Technology Center, Cytometry and Cell Sorting Laboratory, Pre-Clinical Imaging Core, which are partially supported by the Perlmutter Cancer Center Support Grant NIH/NCI 5P30CA016087. We thank the NYU Interdisciplinary Melanoma Cooperative Group (PI: Dr. Iman Osman) for providing access to patient-derived melanoma short-term cultures+ (10-230BM and 12-273BM), which were obtained through IRB-approved protocols (Universal Consent study #s16-00122 and Interdisciplinary Melanoma Cooperative Group study #1....

Materials

NameCompanyCatalog NumberComments
#15 Scapel Blade WPI500242For surgical procedures
#3 Scapel HandleWPI500236For surgical procedures
1 mL Tuberculin syringe, slip tip BD309626Injections
10 mL syringe, slip tip BD301029Perfusion
10% Formalin Sodium BufferedEK Industries4499-20LFor perfusion/tissue fixative
15 mL ConicalCorning 430052Cell culture
15 mL Conical Polypropylene Centrifuge TubesFalcon352196Cell culture
200 Proof EthanolDeacon Labs04-355-223Histology
22G – 22mm needleBD305156Perfusion
4-0 Vicryl SutureEthiconJ464GSuture
4% Carson's phosphate buffered paraformaldehyde EMS15733-10For perfusion/tissue fixative
40µmCorning431750Tissue processing
5-0 Absorbable Suture Ethicon6542000Closure
50 mL Conical Corning 430828Cell culture
50mL Conical Polypropylene Centrifuge TubesFalcon352070Cell culture
7-0 Silk suture FST18020-70Ligature
70µmCorning431751Tissue processing
Anti-fade mounting media  Vector LabsH-1000-10Immunofluorescence
Approximator applying Forceps, 10cm WPI14189For microsurgical procedures
AvanceBruker3 HDNMR Console 
Biospec 7030 Bruker7030Micro MRI
BSABioregA941NuMA Staining
Castroviejo suturing forceps, straight tips 5.5mm tying platform, 11cm WPIWP5025501For microsurgical procedures
Coplin Staining JarBel-Art F44208-1000Histology
DAPISigma-AldrichD9542-1MGImmunofluorescence
dCas9-KRABAddgene110820Genetic manipulation
DNase INEBM0303LTissue processing
DPBSCorning21-030-CMTissue processing
Extra Sharp Uncoated Single Edge BladeGEM62-0167Tissue processing
Extracellular Matrix Substrate Corning354234Consider the Growth Factor Reduced ( as alternative 
FBSCytivaSH30910.03Cell culture
Fiji Image JFiji Image JSoftwareImmunofluorescence
Goat anti-rabbit HRP conjugated multimer Thermo FisherA16104NuMA Staining
Goat SerumGibcoPCN5000Immunofluorescence
HBSSCorning21-020-CVTissue processing
Hematoxylin Richard-Allan Scientific 7231Histology
Illumina III PerkinElmerCLS136334BLI Instrument
Insulin syringe 28G - 8mm needleBD329424Injections
Insulin syringe 31G - 6mm needle BD326730Injections
Iris Forceps, 10.2cm, Full Curve, serratedWPI504478For perfusion and surgical procedures
Isoflurane USPCovetrus11695067772Anesthesia
Jewelers #7 Forceps Titanium 11 cm 0.07 x 0.01 mm TipWPIWP6570For microsurgical procedures
Ketamine HCl 100mg/mLMylan Ind.1049007Anesthesia
lentiCRISPRv2Addgene98290Genetic manipulation
Lycopersicon Esculentum (Tomato) Lectin, DyLight 649InvitrogenL32472Vascular endothelial cells marker
MEM non-essential amino acids X 100Corning25-025-CICell culture
Metzenbaum ScissorsWPI503269For surgical procedures
Microinjection UnitKOPF5000Intracardiac injections
NaClFisherS25877 NuMA Staining
Needle 30G x 25mmBD305128Intracardiac Injection
Needle 33G x 15mmHamilton7747-01Intracarotid Injection
Needle holder, Castroviejo, 14cm, with lock, 1.2mm Serrated JawsWPI14137-GFor microsurgical procedures
NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ miceThe Jackson Laboratory005557Murine model
NU/J miceThe Jackson Laboratory002019Murine model
Nuclear Mitotic Apparatus Protein polyclonal rabbit anti-human Abcam97585NuMA Staining
Penicillin-Streptomycin 10000U/mLGibco15140122Cell culture
PercollGE0891-01density separation solution 
PI Classic Surgical GlovesCardinal Health2D72PT75XSurgery
pLKO Tet-OnAddgene21915Genetic manipulation
Povidone-Iodine 10% SolutionMedlineMDS093943Surgery
Proparacaine Drops 0.5%Akorn PharmaAX0501Opthalmic local anesthetic
Puralube Petrolatum Opthalmic OintmentDechra83592Anesthesia
Razor Blade Double Edge Blades EMS72000Shaving and Vibrotome Brain Slicing 
Reflex 9mm EZ Clip BraintreeEZC- KITWound closure
RPMI 1640 Corning10-040-CMCell culture
Scissors, Spring 10.5cm Str, 8mm BladesWPI501235For microsurgical procedures
Semi-Automatic Vibrating Blade MicrotomeLeicaVT1200Brain Slice Immunofluorescence
Single Channel Anesthesia Vaporizer SystemKent ScientificVetFlo-1210S Anesthesia
Smartbox Tabletop Chamber System and Exhaust BlowerEZ SystemsTT4000CO2 Euthanasia
Sterile Fenestrated Disposable DrapeMedlineNON21002Surgery
Sterile Non-Reinforced Aurora Surgical Gowns with Set-In SleevesMedlineDYNJP2715Surgery
T25 FlaskCorning 430639Cell culture
TrisCorning46-031-CMNuMA Staining
Triton X-100Sigma-AldrichX100-500MLImmunofluorescence
Troutman tying forceps, 10cm, Curved G pattern, 0.52mm tip with tying platformWPIWP505210For microsurgical procedures
Vessel clips 10G Pressure 5x 0.8mm Jaws, 5/pkgWPI15911For microsurgical procedures
VisiopharmVisiopharmVisiopharmNuMA Staining Quantification Software
Xylasine 100mg/mLAkorn Pharma59399-111-50Anesthesia
XyleneFisherX3P-1GALHistology

References

  1. Sung, H., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 71 (3), 209-249 (2021).
  2. Adler, N. R., Haydon, A., McLean, C. A., Kelly, J. W., Mar, V. J.

Explore More Articles

Melanoma MetastasisIn Vivo ModelsTarget DiscoveryTherapy DevelopmentIntradermal InjectionIntracardiac InjectionTumor Growth MonitoringUltrasound Guidance

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved